Malaysia Joins COVAX Vaccine Plan, Also In Deals With China, Pharma Companies

Daniel Fowler
September 19, 2020

As part of its new push, the Commission is urging the 27 European Union member states' governments to back negotiations with a seventh vaccine maker, the two sources said, after it reached deals with AstraZeneca and Sanofi and announced advanced talks with Johnson & Johnson, Moderna, Pfizer and CureVac for their potential COVID-19 shots.

Bancel noted that if the rate of infections in the USA slows dramatically in the coming weeks, it could delay the results of the trial.

Trump's Democratic rival, Joe Biden, said Wednesday though he's a fan of vaccines, he's not sure he would trust one approved before the November 3 election.

The vaccine race has become deeply politicized in the USA in the run-up to the presidential election in November.

As of Thursday, Moderna had recruited 25,296 volunteers.

Also, in an exchange filing, Zydus Cadila said that it has received final approval from the USFDA to market Potassium Chloride ExtendedRelease Tablets (US RLD: K-Dur Extended-Release Tablets) in the strengths of 10 mEq (750 mg) and 20 mEq (1500 mg). Two other vaccines also are being tested with mRNA-1647 ready for a phase 3 trial next year.

It'll take a few more weeks to recruit the full quotient of 30,000 participants and for them to receive their second doses.

New Cases; Five Hospitalized At BMH
No new cases were found in the Island Health region since Thursday, leaving the health authority's total number of cases at 196. Statewide there have been 60,128 positive cases of the COVID-19 virus in Kentucky, and 1,101 total deaths from the virus.

The group further warns that even if the five potential vaccines turn out to be sufficiently safe and effective-an unlikely scenario-the coming year would still be marked by the public health crisis because 61% of the world's population would likely not have a vaccine until at least 2022.

The FDA has stated its bar for approval is a vaccine that reduces the risk of falling sick with Covid-19 by 50 percent. Phase 3 trials, being large enough, can also reveal rare side effects that could have been missed in earlier smaller studies.

"This has the key information for stopping rules, interim analyses and efficacy assumptions. Applaud their transparency", Eric Topol, an independent expert who has been sounding the alarm on the need to guard against political interference, told AFP.

Having a sufficient number of black and Hispanic participants, in particular, is seen as crucial to obtain a statistically representative results for these groups, which have been disproportionately hit by the pandemic.

India is the manufacturing partner of Covishield, a vaccine candidate developed jointly by the University of Oxford's Jenner Institute and AstraZeneca.

The Health Ministry and UNICEF signed on Wednesday an agreement on the procurement of COVID-19 vaccine under the COVAX Facility, a global COVID-19 vaccine allocation plan co-led by the World Health Organization that aims to help buy and fairly distribute the vaccine. The US remains the exception for reasons that aren't yet known.

Other reports by

Discuss This Article